Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Supernus Pharmaceuticals Inc (NASDAQ:SUPN)

39.65
Delayed Data
As of Dec 15
 0.00 / 0.00%
Today’s Change
22.70
Today|||52-Week Range
50.05
+57.03%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 4
2016
Quarter 1
2017
Quarter 2
2017
Quarter 3
2017
Revenue and IncomeNet Revenues62.4M57.6M75.8M80.4M
 
 
 
 
 
Cost of Goods Sold3.1M2.2M2.6M2.1M
 
 
 
 
 
Depreciation And Amortization671.0K741.0K1.3M4.4M
 
 
 
 
 
 
Operating ExpensesGross Income58.6M54.6M72.0M74.0M
 
 
 
 
 
General Expenses42.3M37.8M45.9M51.6M
 
 
 
 
 
Research And Development13.3M9.6M10.8M13.0M
 
 
 
 
 
Total Operating Expenses46.1M40.8M49.8M58.1M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income16.3M16.8M26.1M22.3M
 
 
 
 
 
Extraordinary Credit100.0K54.0K23.0K0.00
 
 
 
 
Extraordinary Charge-289.0K-101.0K-103.0K-91.0K
 
 
 
 
 
Interest Expense On Debt951.0K1.0M218.0K155.0K
 
 
 
 
 
Other Expenses-13.0K0.000.000.00
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income15.6M16.2M26.4M22.9M
 
 
 
 
 
Income Taxes-1.2M-5.9M-9.1M-6.9M
 
 
 
 
 
Net Income14.3M10.3M17.4M16.0M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS49.7M50.2M50.5M51.0M
 
 
 
 
 
Shares To Calculate EPS Diluted52.0M52.8M53.2M53.6M
 
 
 
 
 
 
Earnings Per ShareEPS$0.26$0.19$0.32$0.29
 
 
 
 
 
EPS Diluted$0.28$0.19$0.32$0.29